Extramammary Paget disease

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

7 events
Dec 2025Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Sheng Zhang — PHASE2

TrialRECRUITING
Aug 2025A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease

Fudan University — PHASE2

TrialRECRUITING
Mar 2025A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

Memorial Sloan Kettering Cancer Center — PHASE2

TrialRECRUITING
Jan 2025A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum

Fujian Medical University Union Hospital — PHASE2

TrialRECRUITING
Aug 2024A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.

Fudan University — PHASE2

TrialRECRUITING
Aug 2019PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).

University Hospital, Lille — NA

TrialRECRUITING
Feb 2018Gynecologic Extramammary Paget's Disease

Mayo Clinic

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Extramammary Paget disease.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials
2Phase 2
1Unknown
3Total recruiting
Search clinical trials for Extramammary Paget disease

Recent News & Research

No recent news articles indexed yet for Extramammary Paget disease.
Search PubMed for Extramammary Paget disease

Browse all Extramammary Paget disease news →

Specialist Network

Top 6 by expertise

View all Extramammary Paget disease specialists →

Quick Actions